These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15988377)

  • 1. [RET mutations and preventive treatment of medullary thyroid cancer].
    Niccoli-Sire P; Conte-Devolx B;
    Ann Endocrinol (Paris); 2005 Jun; 66(3):168-75. PubMed ID: 15988377
    [No Abstract]   [Full Text] [Related]  

  • 2. The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case.
    Aiello A; Cioni K; Gobbo M; Collini P; Gullo M; Della Torre G; Passerini E; Ferrando B; Pilotti S; Pierotti MA; Pasini B
    Surgery; 2005 May; 137(5):574-6. PubMed ID: 15855933
    [No Abstract]   [Full Text] [Related]  

  • 3. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
    Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
    Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 2A in Chinese families.
    Lo CY; Wat NM; Lam KY; Tiu SC; Chan J; Lam KS
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):528. PubMed ID: 12641638
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple endocrine neoplasia 2A type: a genetic study of one family].
    Arias Miranda IM; Casal Alvarez F; Castaño L
    Med Clin (Barc); 2005 Jan; 124(3):116. PubMed ID: 15710101
    [No Abstract]   [Full Text] [Related]  

  • 6. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
    Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH
    Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.
    Kahraman T; de Groot JW; Rouwe C; Hofstra RM; Links TP; Sijmons RH; Plukker JT
    Eur J Surg Oncol; 2003 May; 29(4):331-5. PubMed ID: 12711285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of RET proto-oncogene codon 609 germline mutations with RET haplotypes characterized by c.135G>A alleles modifying MEN 2A or HSCR phenotypes.
    Fitze G; Schreiber M; Hohenberger W; Hümmer HP; Roesner D; Schackert HK
    Am J Med Genet A; 2004 Sep; 129A(3):323-5. PubMed ID: 15326638
    [No Abstract]   [Full Text] [Related]  

  • 10. A RET C634R mutation in a Thai female with multiple endocrine neoplasia type 2A.
    Sunthornyothin S; Sinthuwiwat T; Shotelersuk V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S472-6. PubMed ID: 12930027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer.
    Fernandez RM; Robledo M; Antinolo G; Pecina A; Ruiz-Llorente S; Eng C; Borrego S
    Thyroid; 2004 Apr; 14(4):329-31. PubMed ID: 15142370
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634.
    Gimm O; Ukkat J; Niederle BE; Weber T; Thanh PN; Brauckhoff M; Niederle B; Dralle H
    World J Surg; 2004 Dec; 28(12):1312-6. PubMed ID: 15517481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 2.
    Forster-Gibson CJ; Mulligan LM
    Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
    Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
    Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medullary cancers of the thyroid: genetic aspects].
    Orgiazzi J
    Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
    Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.